Page 89 - GPD-3-2
P. 89

Gene & Protein in Disease                                          A review of exosome-mediated treatments



            own blood, is rich in platelets and growth factors that   alopecia have included minimal pain at the injection site in
            promote wound healing and tissue repair.  When     the scalp for up to 2 days following treatment. 21
                                                   19
            combined with exosomes, which have shown the ability   Furthermore, the  versatility  of exosomes allows for
            to stimulate DSC proliferation and promote hair follicle   combination therapies, such as co-administration with
            growth, the combined effects can potentially enhance hair   growth  factors  or other  regenerative agents,  potentially
            regeneration outcomes.  Injection techniques are used,                 2,23
                               20
            such as microneedling or direct injection, to facilitate   amplifying their efficacy.  As research progresses, the
            precise delivery to the scalp. Due to limitations in   identification of optimal dosage, frequency, and delivery
            current medicinal therapies for hair loss (e.g., variability,   methods will refine the application of exosomes in alopecia
            ineffectiveness, non-compliance, and adverse effects),   management, ushering in a new era of personalized and
            regenerative strategies such as PRP and cell-based   effective treatments.
            therapies, including those employing exosomes, offer a   The potential advantages of exosome-based therapies
            comprehensive approach to conditions such as alopecia.    over currently available dermatological treatments, such
                                                         20
            Further research and clinical trials are needed to fully   as their ability to address multiple aspects of skin health
            elucidate the efficacy and optimal protocols for this   and regeneration, are presented in Table 1. This table also
            combination therapy. That being said, understanding the   underscores the need for more comparative clinical studies
            nuances of these mechanisms is critical for improving   to fully evaluate the efficacy and safety of exosome-based
            exosome therapies for different types of alopecias to   interventions in relation to standard-of-care options.
            enhance and optimize treatment precision.          Addressing these knowledge gaps will be crucial for the

            2.1.2. Potential applications and benefits         successful integration of exosome-based therapies into
                                                               dermatological practice. The various applications are also
            The potential applications of exosomes in treating alopecias   demonstrated in Figure 2.
            extend  beyond  traditional  approaches.  Exosomes  offer  a
            non-invasive and targeted therapeutic option, allowing   2.2. Efficacy in wound healing
            us to circumvent the limitations associated with current   2.2.1. Examination of studies showcasing exosome
            treatments, such as topical minoxidil or oral medications,   effectiveness
            which can accompanied by side effects, systemic impact,
            and the need for long-term adherence.  In addition, the   Studies investigating the role of exosomes in wound
                                            21
            regenerative potential of exosomes can not only halt hair   healing have demonstrated their remarkable effectiveness
            loss but also stimulate the growth of new, healthy hair.    in accelerating the regenerative processes of the skin.
                                                         22
                                                                                                            24
            Side effects of exosome use in the treatment of androgenetic   These studies often utilize both  in vitro and  in vivo
            Table 1. Comparative analysis of exosome-based therapies and current dermatological treatments

            Condition         Exosome-based therapy    Current treatments          Comparative outcomes
            Alopecia     (i)     Stimulated hair follicle growth and   (i)    Topical minoxidil  (i)   Exosomes showed promising hair regenerative
                            proliferation of dermal papilla cells  (ii)   Oral finasteride  effects, potentially overcoming limitations of
                         (ii)    Increased hair density and   (iii)  Low-level light therapy  existing treatments (e.g., side effects, long-term
                            thickness in clinical studies                   adherence)
            Wound healing  (i)    Accelerated wound closure and   (i)      Topical wound dressings  (i)   Exosomes demonstrated the ability to orchestrate
                           re-epithelialization     (ii)     Growth factor therapies   multiple stages of wound healing, offering a more
                         (ii)    Enhanced angiogenesis and tissue   Negative pressure wound   comprehensive therapeutic approach
                            remodeling                  therapy
                         (iii)  Modulated inflammatory response
            Skin aging   (i)     Promoted collagen production and   (i)     Topical retinoids  (i)   Exosomes exhibited rejuvenating effects on aging
                            reduced oxidative stress  (ii)   Antioxidant serums  skin, potentially providing a more targeted and
                         (ii)   Improved skin texture and elasticity (iii)  Laser treatments  natural alternative to current anti-aging interventions
            Acne         (i)     Reduced inflammation and sebum   (i)     Topical retinoids  (i)   Exosomes showed promise as an adjunct therapy to
                            production              (ii)    Oral antibiotics  enhance the outcomes of existing acne treatments,
                         (ii)   Improved appearance of acne scars  (iii)  Hormonal therapies  particularly in addressing scarring
            Pigmentation   (i)     Modulated melanocyte function   (i)      Topical depigmenting   (i)   Exosomes offer a novel approach to targeting
            disorders       and melanin synthesis      agents               the underlying mechanisms of pigmentation
                                                    (ii)   Chemical peels   disorders, potentially leading to more effective and
                                                    (iii)  Laser treatments  personalized treatments


            Volume 3 Issue 2 (2024)                         5                               doi: 10.36922/gpd.3230
   84   85   86   87   88   89   90   91   92   93   94